Branimycins B and C, Antibiotics Produced by the Abyssal Actinobacterium Pseudonocardia carboxydivorans M-227

Journal of Natural Products

Volumn 80, Issue 2, 2017, Pages 569-573

  Braña, Alfredo F ^a   Sarmiento Vizcaíno, Aida ^a   Pérez Victoria, Ignacio ^b   Otero, Luis ^c   Fernández, Jonathan ^d   Palacios, Juan José ^d   Martín, Jesús ^b   De La Cruz, Mercedes ^b   Díaz, Caridad ^b   Vicente, Francisca ^b   Reyes, Fernando ^b   García, Luis A ^e   Blanco, Gloria ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Fundación MEDINA Centro de Excelencia en Investigaciovn de Medicamentos Innovadores en Andalucía   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; BRANIMYCIN B; BRANIMYCIN C; NATURAL PRODUCT; PENICILLIN G; SEA WATER; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; BRANIMYCIN; MACROLIDE;

ACINETOBACTER BAUMANNII; ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEROIDES FRAGILIS; CARBON NUCLEAR MAGNETIC RESONANCE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CORYNEBACTERIUM UREALYTICUM; DRUG ISOLATION; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HETERONUCLEAR MULTIPLE BOND CORRELATION; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; PSEUDONOCARDIA; PSEUDONOCARDIA CARBOXYDIVORANS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; NUCLEAR MAGNETIC RESONANCE;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECALIS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HAEMOPHILUS INFLUENZAE; MACROLIDES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 85013846113     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/acs.jnatprod.6b01107     Document Type: Article

References (18)

1. Celmer, W. D., Cullen, W. P., Moppet, C. E., Jefferson, M. T., Huang, L. H., Shibakawa, R., and Junsuki, T. U.S. Patent 4,148,883, 1979.
2. Celmer, W. D.; Chmurny, G. N.; Moppett, C. E.; Ware, R. S.; Watts, P. C.; Whipple, E. B. Structure of natural antibiotic CP-47,444 J. Am. Chem. Soc. 1980, 102, 4203-4209 10.1021/ja00532a036
3. Speitling, M. Vergleich der metabolischen Kapazität mariner und terrestrischer Mikroorganismen-Isolierung und Strukturaufklärung von Branimycin, Brom-alterochromid A/B und weiteren Stoffwechselprodukten. Thesis dissertation. University of Göttingen, 1998.
4. Marchart, S.; Gromov, A.; Mulzer, J. Angew. Chem., Int. Ed. 2010, 49, 2050-2053 10.1002/anie.200906453
5. Enev, V. S.; Felzmann, W.; Gromov, A.; Marchart, S.; Mulzer, J. Chem.-Eur. J. 2012, 18, 9651-9668 10.1002/chem.201200257
6. Dudfield, P. J.; Lowther, J.; Delachaume, C. A. J.; Lépine, R. H. M.; Thys, A. P. M.; Doyon, J. G. P. O.; Toumi, M. P.; Hansske, F. G. Int. Patent WO 2015/028094 A1, 2015.
7. Čikoš, A.; Triballeau, N.; Hubbard, P. A.; Žiher, D.; Stouten, P. F. W.; Doyon, J. G. P. O.; Deschrijver, T.; Wouters, J.; Lépine, R. H. M.; Saniere, L. Org. Lett. 2016, 18, 780-783 10.1021/acs.orglett.6b00044
8. Manivasagan, P.; Venkatesan, J.; Sivakumar, K.; Kim, S. K. Microbiol. Res. 2014, 169, 262-278 10.1016/j.micres.2013.07.014
9. Bull, A. T.; Ward, A. C.; Goodfellow, M. Microbiol. Mol. Biol. Rev. 2000, 64, 573-606 10.1128/MMBR.64.3.573-606.2000
10. Braña, A. F.; Fiedler, H. P.; Nava, H.; González, V.; Sarmiento-Vizcaíno, A.; Molina, A.; Acuña, J. L.; García, L. A.; Blanco, G. Microb. Ecol. 2015, 69, 512-524 10.1007/s00248-014-0508-0
11. Sarmiento-Vizcaíno, A.; Braña, A. F.; González, V.; Nava, H.; Molina, A.; Llera, E.; Fiedler, H.-P.; Rico, J. M.; García-Flórez, L.; Acuña, J. L.; García, L. A.; Blanco, G. Microb. Ecol. 2016, 71, 375-386 10.1007/s00248-015-0654-z
12. Sarmiento-Vizcaíno, A.; González, V.; Braña, A. F.; Molina, A.; Acuña, J. L.; García, L. A.; Blanco, G. Int. J. Syst. Evol. Microbiol. 2015, 65, 1328-1334 10.1099/ijs.0.000107
13. Sarmiento-Vizcaíno, A.; González, V.; Braña, A. F.; Palacios, J. J.; Otero, L.; Fernández, J.; Molina, A.; Kulik, A.; Vázquez, F.; Acuña, J. L.; García, L. A.; Blanco, G. Microb. Ecol. 2017, 73, 338-352 10.1007/s00248-016-0845-2
14. Pérez-Victoria, I.; Martín, J.; Reyes, F. Planta Med. 2016, 82, 857-871 10.1055/s-0042-101763
15. Braña, A. F.; Rodríguez, M.; Pahari, P.; Rohr, J.; García, L. A.; Blanco, G. Arch. Microbiol. 2014, 196, 345-55 10.1007/s00203-014-0977-z
16. Audoin, C.; Bonhomme, D.; Ivanisevic, J.; de la Cruz, M.; Cautain, B.; Monteiro, M. C.; Reyes, F.; Rios, L.; Perez, T.; Thomas, O. P. Mar. Drugs 2013, 11, 1477-1489 10.3390/md11051477
17. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Fourth Informational Supplement. CLSI document M100-S24; Clinical and Laboratory Standards Institute: Wayne, PA, 2014.
18. CLSI. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes, Approved Standard, Second ed. CLSI document M-24-A2; Clinical and Laboratory Standards Institute: Wayne, PA, 2011.